Scholarly Activity

2022-2023

• Incidence of Behavioral Side Effects with Brivaracetam in Children and Adolescents
• Evaluation of Octreotide Safety and Efficacy for Chylothorax in Pediatric Patients

2021-2022

• Evaluation of Pain Control Between Verbal and Non-verbal Cerebral Palsy Patients During a 24-hour Post-Operative Period
• Evaluation of REGEN-COV (casirivimab and imdevimab ) use in pediatric patients for the treatment of mild to moderate COVID-19 disease

2020-2021

• Incidence of hyponatremia with the use of vasopressin in pediatric patients
• Evaluation of advancing chemotherapy administration times and the incidence of hemorrhagic cystitis/hematuria

2019-2020

• Utilization of Intravenous Clonidine in a Neonatal Intensive Care Unit
• Retrospective review of IVIG usage and potential cost savings analysis at a children's hospital

2018-2017

• Evaluation of Advancing Chemotherapy Administration Times and the Incidence of Hemorrhagic Cystitis
• Evaluation of peri-extubation propofol washout in critically ill children undergoing prolonged mechanical ventilation

2017-2018

• Retrospective analysis of opioid rotation strategies in the pediatric intensive care unit
• Retrospective Evaluation of Empiric Vancomycin Dosing at a Children’s Hospital

2016-2017

• Incidence of hyponatremia with the use of vasopressin in pediatric patients

2015-2016

• Impact of Medication Education Service by Pharmacy Interns on HCAHPS Scores in a Pediatric Hospital
• Retrospective Review of Auto-verified Orders in a Pediatric Emergency Department Before and After Pharmacist-driven Provider Education

2022-2023

• Evaluations of Clinical and Bacteriological Outcomes of Vancomycin AUC/MIC Monitoring in Pediatric Patients Treated for Organisms other than Methicillin-Resistant Staphylococcus aureus (MRSA)